Prospective Surveillance of Primary Healthcare Presentations for Scabies and Bacterial Skin Infections in Fiji, 2018-2019.


Journal

The American journal of tropical medicine and hygiene
ISSN: 1476-1645
Titre abrégé: Am J Trop Med Hyg
Pays: United States
ID NLM: 0370507

Informations de publication

Date de publication:
24 05 2021
Historique:
received: 11 11 2020
accepted: 24 03 2021
pubmed: 25 5 2021
medline: 1 2 2022
entrez: 24 5 2021
Statut: epublish

Résumé

Scabies, impetigo, and other skin and soft tissue infections (SSTIs) are highly prevalent in many tropical, low-middle income settings, but information regarding their burden of disease is scarce. We conducted surveillance of presentations of scabies and SSTIs, including impetigo, abscesses, cellulitis, and severe SSTI, to primary health facilities in Fiji. We established a monthly reporting system over the course of 50 weeks (July 2018-June 2019) for scabies and SSTIs at all 42 public primary health facilities in the Northern Division of Fiji (population, ≈131,914). For each case, information was collected regarding demographics, diagnosis, and treatment. There were 13,736 individual primary healthcare presentations with scabies, SSTI, or both (108.3 presentations per 1000 person-years; 95% confidence interval [CI], 106.6-110 presentations). The incidence was higher for males than for females (incidence rate ratio [IRR], 1.15; 95% CI, 1.11-1.19). Children younger than 5 years had the highest incidence among all age groups (339.1 per 1000 person-years). The incidence was higher among the iTaukei (indigenous) population (159.9 per 1000 person-years) compared with Fijians of Indian descent (30.1 per 1000 person-years; IRR, 5.32; 95% CI, 5.03-5.61). Abscess was the condition with the highest incidence (63.5 per 1,000 person-years), followed by scabies (28.7 per 1,000 person-years) and impetigo (21.6 per 1,000 person-years). Scabies and SSTIs impose a substantial burden in Fiji and represent a high incidence of primary health presentations in this population. The incidence in low-middle income settings is up to 10-times higher than that in high-income settings. New public health strategies and further research are needed to address these conditions.

Identifiants

pubmed: 34029210
doi: 10.4269/ajtmh.20-1459
pii: tpmd201459
pmc: PMC8274759
doi:
pii:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

230-237

Auteurs

Li Jun Thean (LJ)

1Tropical Diseases Group, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.
2Department of Paediatrics, University of Melbourne, Melbourne, Victoria, Australia.

Lucia Romani (L)

1Tropical Diseases Group, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.
3Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia.

Daniel Engelman (D)

1Tropical Diseases Group, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.
2Department of Paediatrics, University of Melbourne, Melbourne, Victoria, Australia.
4Melbourne Children's Global Health, Melbourne Children's Campus, The Royal Children's Hospital, Melbourne, Australia.

Adam Jenney (A)

5College of Medicine, Nursing and Health Sciences, Fiji National University, Suva, Fiji.
6Department of Infectious Diseases, The Alfred Hospital and Monash University, Melbourne, Victoria, Australia.

Handan Wand (H)

3Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia.

Jyotishna Mani (J)

1Tropical Diseases Group, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.

Jessica Paka (J)

1Tropical Diseases Group, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.

Rachel Devi (R)

7Ministry of Health and Medical Services, Suva, Fiji.

Aalisha Sahukhan (A)

7Ministry of Health and Medical Services, Suva, Fiji.

Mike Kama (M)

7Ministry of Health and Medical Services, Suva, Fiji.

Meciusela Tuicakau (M)

7Ministry of Health and Medical Services, Suva, Fiji.

Joseph Kado (J)

7Ministry of Health and Medical Services, Suva, Fiji.
8Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, Perth, Western Australia.
9Faculty of Health and Medical Sciences, University of Western Australia, Perth, Western Australia.

Natalie Carvalho (N)

10School of Population and Global Health, University of Melbourne, Melbourne, Victoria, Australia.

Margot Whitfeld (M)

11Department of Dermatology, St. Vincent's Hospital, Sydney, New South Wales, Australia.
12School of Medicine, University of New South Wales, Sydney, New South Wales, Australia.

John Kaldor (J)

3Kirby Institute, University of New South Wales, Sydney, New South Wales, Australia.

Andrew C Steer (AC)

1Tropical Diseases Group, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.
2Department of Paediatrics, University of Melbourne, Melbourne, Victoria, Australia.
4Melbourne Children's Global Health, Melbourne Children's Campus, The Royal Children's Hospital, Melbourne, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH